Published in Diabetes Care on December 01, 2009
Intravitreal Dexamethasone vs Bevacizumab in Aboriginal People With DMO (OASIS) | NCT04619303
Global prevalence and major risk factors of diabetic retinopathy. Diabetes Care (2012) 7.83
The worldwide epidemic of diabetic retinopathy. Indian J Ophthalmol (2012) 1.45
Update on animal models of diabetic retinopathy: from molecular approaches to mice and higher mammals. Dis Model Mech (2012) 1.38
Animal models of diabetic retinopathy: summary and comparison. J Diabetes Res (2013) 1.09
Progression and regression: distinct developmental patterns of diabetic retinopathy in patients with type 2 diabetes treated in the diabetes care system west-friesland, the Netherlands. Diabetes Care (2011) 1.07
Can the retinal screening interval be safely increased to 2 years for type 2 diabetic patients without retinopathy? Diabetes Care (2012) 1.03
A simple risk stratification for time to development of sight-threatening diabetic retinopathy. Diabetes Care (2012) 1.03
Current treatments in diabetic macular oedema: systematic review and meta-analysis. BMJ Open (2013) 1.00
Assessing progress in retinopathy outcomes in type 1 diabetes: comparing findings from the Wisconsin Diabetes Registry Study and the Wisconsin Epidemiologic Study of Diabetic Retinopathy. Diabetes Care (2012) 0.99
Epidemiological issues in diabetic retinopathy. Middle East Afr J Ophthalmol (2013) 0.97
Predicting development of proliferative diabetic retinopathy. Diabetes Care (2012) 0.95
Development and progression of diabetic retinopathy and associated risk factors in Korean patients with type 2 diabetes: the experience of a tertiary center. J Korean Med Sci (2014) 0.94
Age at onset and the risk of proliferative retinopathy in type 1 diabetes. Diabetes Care (2010) 0.94
Prevalence of diabetic retinopathy in individuals with type 2 diabetes who had recorded diabetic retinopathy from retinal photographs in Catalonia (Spain). Br J Ophthalmol (2015) 0.87
Diabetic retinopathy in 2011: further insights from new epidemiological studies and clinical trials. Diabetes Care (2011) 0.86
High HbA1c level was the most important factor associated with prevalence of diabetic retinopathy in Taiwanese type II diabetic patients with a fixed duration. Graefes Arch Clin Exp Ophthalmol (2013) 0.83
Blood pressure, vessel caliber, and retinal thickness in diabetes. Optom Vis Sci (2012) 0.81
Neuroretinal hypoxic signaling in a new preclinical murine model for proliferative diabetic retinopathy. Signal Transduct Target Ther (2016) 0.79
[Diabetic maculopathy and retinopathy. Functional and sociomedical significance]. Ophthalmologe (2010) 0.77
Review of therapeutic advances in diabetic retinopathy. Ther Adv Endocrinol Metab (2011) 0.77
Cost of diabetic retinopathy and macular oedema in a population, an eight year follow up. BMC Ophthalmol (2016) 0.75
Clinical features of diabetic patients referred by general physicians due to less ophthalmic examinations. Clin Ophthalmol (2014) 0.75
Should we start all patients with diabetic retinopathy on fenofibrates? Middle East Afr J Ophthalmol (2013) 0.75
The United Kingdom Diabetic Retinopathy Electronic Medical Record Users Group: Report 3: Baseline Retinopathy and Clinical Features Predict Progression of Diabetic Retinopathy. Am J Ophthalmol (2017) 0.75
Prevalence of diabetic retinopathy in Iran: a systematic review and Meta-analysis. Int J Ophthalmol (2017) 0.75
Retrospective analysis of newly recorded certifications of visual impairment due to diabetic retinopathy in Wales during 2007-2015. BMJ Open (2017) 0.75
Meta-analysis in clinical trials. Control Clin Trials (1986) 144.91
The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group. N Engl J Med (1993) 102.56
Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst (1959) 94.48
Photocoagulation for diabetic macular edema. Early Treatment Diabetic Retinopathy Study report number 1. Early Treatment Diabetic Retinopathy Study research group. Arch Ophthalmol (1985) 17.20
Lifetime risk for diabetes mellitus in the United States. JAMA (2003) 10.33
Fundus photographic risk factors for progression of diabetic retinopathy. ETDRS report number 12. Early Treatment Diabetic Retinopathy Study Research Group. Ophthalmology (1991) 7.27
Early photocoagulation for diabetic retinopathy. ETDRS report number 9. Early Treatment Diabetic Retinopathy Study Research Group. Ophthalmology (1991) 5.91
The Wisconsin Epidemiologic Study of Diabetic Retinopathy: XVII. The 14-year incidence and progression of diabetic retinopathy and associated risk factors in type 1 diabetes. Ophthalmology (1998) 4.21
Prevention and early detection of vascular complications of diabetes. BMJ (2006) 4.14
Management of diabetic retinopathy: a systematic review. JAMA (2007) 3.47
Important causes of visual impairment in the world today. JAMA (2003) 3.43
Decreasing incidence of severe diabetic microangiopathy in type 1 diabetes. Diabetes Care (2003) 3.12
Effect of candesartan on progression and regression of retinopathy in type 2 diabetes (DIRECT-Protect 2): a randomised placebo-controlled trial. Lancet (2008) 2.89
Diabetic retinopathy and diabetic macular edema: pathophysiology, screening, and novel therapies. Diabetes Care (2003) 2.88
The Wisconsin epidemiologic study of diabetic retinopathy. XI. The incidence of macular edema. Ophthalmology (1989) 2.51
Effect of candesartan on prevention (DIRECT-Prevent 1) and progression (DIRECT-Protect 1) of retinopathy in type 1 diabetes: randomised, placebo-controlled trials. Lancet (2008) 2.49
The Wisconsin Epidemiologic Study of Diabetic Retinopathy. X. Four-year incidence and progression of diabetic retinopathy when age at diagnosis is 30 years or more. Arch Ophthalmol (1989) 2.31
Digital retinal images and teleophthalmology for detecting and grading diabetic retinopathy. Diabetes Care (2002) 2.31
Methodology for retinal photography and assessment of diabetic retinopathy: the EURODIAB IDDM complications study. Diabetologia (1995) 2.27
How effective are treatments for diabetic retinopathy? JAMA (1993) 2.25
Photocoagulation for diabetic macular edema: Early Treatment Diabetic Retinopathy Study Report no. 4. The Early Treatment Diabetic Retinopathy Study Research Group. Int Ophthalmol Clin (1987) 1.99
Cost effectiveness analysis of screening for sight threatening diabetic eye disease. BMJ (2000) 1.92
Declining incidence of severe retinopathy and persisting decrease of nephropathy in an unselected population of Type 1 diabetes-the Linköping Diabetes Complications Study. Diabetologia (2004) 1.92
Effect of ruboxistaurin in patients with diabetic macular edema: thirty-month results of the randomized PKC-DMES clinical trial. Arch Ophthalmol (2007) 1.77
Declining incidence of nephropathy in insulin-dependent diabetes mellitus. N Engl J Med (1994) 1.69
Report from the NEI/FDA Ophthalmic Clinical Trial Design and Endpoints Symposium. Invest Ophthalmol Vis Sci (2008) 1.58
Effects of aspirin treatment on diabetic retinopathy. ETDRS report number 8. Early Treatment Diabetic Retinopathy Study Research Group. Ophthalmology (1991) 1.28
Incidence of ESRD and survival after renal replacement therapy in patients with type 1 diabetes: a report from the Allegheny County Registry. Am J Kidney Dis (2003) 1.07
The relationships between risk factors and the distribution of retinopathy lesions in type 2 diabetes. Acta Ophthalmol Scand (2006) 0.90
Prevalence of age-related macular degeneration in the United States. Arch Ophthalmol (2004) 18.86
Causes and prevalence of visual impairment among adults in the United States. Arch Ophthalmol (2004) 13.78
Global prevalence and major risk factors of diabetic retinopathy. Diabetes Care (2012) 7.83
Renal and retinal effects of enalapril and losartan in type 1 diabetes. N Engl J Med (2009) 6.75
The prevalence of diabetic retinopathy among adults in the United States. Arch Ophthalmol (2004) 6.53
Diabetic retinopathy. N Engl J Med (2012) 5.79
Prevalence of open-angle glaucoma among adults in the United States. Arch Ophthalmol (2004) 5.44
Diabetic retinopathy. Lancet (2010) 5.38
Glycemic index, glycemic load, and chronic disease risk--a meta-analysis of observational studies. Am J Clin Nutr (2008) 5.07
Diabetic retinopathy in a multi-ethnic cohort in the United States. Am J Ophthalmol (2006) 4.68
The prevalence of refractive errors among adults in the United States, Western Europe, and Australia. Arch Ophthalmol (2004) 4.64
The association of aspirin use with age-related macular degeneration. JAMA Intern Med (2013) 4.62
The Age-Related Eye Disease Study severity scale for age-related macular degeneration: AREDS Report No. 17. Arch Ophthalmol (2005) 4.46
Prevalence of diabetic retinopathy in the United States, 2005-2008. JAMA (2010) 4.41
Genetic variants near TIMP3 and high-density lipoprotein-associated loci influence susceptibility to age-related macular degeneration. Proc Natl Acad Sci U S A (2010) 4.30
Retinopathy in diabetes. Diabetes Care (2004) 4.25
Age-related macular degeneration. Lancet (2012) 4.17
Outdoor activity reduces the prevalence of myopia in children. Ophthalmology (2008) 3.99
The impact of hearing loss on quality of life in older adults. Gerontologist (2003) 3.87
Central serous chorioretinopathy. Acta Ophthalmol (2007) 3.83
Seven new loci associated with age-related macular degeneration. Nat Genet (2013) 3.81
A simplified severity scale for age-related macular degeneration: AREDS Report No. 18. Arch Ophthalmol (2005) 3.74
Risk factors for incident age-related macular degeneration: pooled findings from 3 continents. Ophthalmology (2004) 3.53
Revised formulas for summarizing retinal vessel diameters. Curr Eye Res (2003) 3.47
Prevalence of olfactory impairment in older adults. JAMA (2002) 3.46
Relation between fasting glucose and retinopathy for diagnosis of diabetes: three population-based cross-sectional studies. Lancet (2008) 3.42
Safety and efficacy of ranibizumab in diabetic macular edema (RESOLVE Study): a 12-month, randomized, controlled, double-masked, multicenter phase II study. Diabetes Care (2010) 3.29
Risk factors for the incidence of Advanced Age-Related Macular Degeneration in the Age-Related Eye Disease Study (AREDS) AREDS report no. 19. Ophthalmology (2005) 3.28
Potential public health impact of Age-Related Eye Disease Study results: AREDS report no. 11. Arch Ophthalmol (2003) 3.17
The 5-year incidence and progression of hearing loss: the epidemiology of hearing loss study. Arch Otolaryngol Head Neck Surg (2003) 3.17
The prevalence of retinal vein occlusion: pooled data from population studies from the United States, Europe, Asia, and Australia. Ophthalmology (2010) 3.08
The 30-year natural history of type 1 diabetes complications: the Pittsburgh Epidemiology of Diabetes Complications Study experience. Diabetes (2006) 3.00
Diabetic retinopathy. Diabetes Care (2004) 2.97
Dissection of genomewide-scan data in extended families reveals a major locus and oligogenic susceptibility for age-related macular degeneration. Am J Hum Genet (2003) 2.92
The economic burden of major adult visual disorders in the United States. Arch Ophthalmol (2006) 2.92
The association among smoking, heavy drinking, and chronic kidney disease. Am J Epidemiol (2006) 2.89
Effect of candesartan on progression and regression of retinopathy in type 2 diabetes (DIRECT-Protect 2): a randomised placebo-controlled trial. Lancet (2008) 2.89
Open-angle glaucoma and cardiovascular mortality: the Blue Mountains Eye Study. Ophthalmology (2006) 2.87
Vision loss in Australia. Med J Aust (2005) 2.86
Retinal vascular caliber and the development of hypertension: a meta-analysis of individual participant data. J Hypertens (2014) 2.83
Retinal vascular caliber, cardiovascular risk factors, and inflammation: the multi-ethnic study of atherosclerosis (MESA). Invest Ophthalmol Vis Sci (2006) 2.79
Retinal arteriolar narrowing and risk of coronary heart disease in men and women. The Atherosclerosis Risk in Communities Study. JAMA (2002) 2.78
Homocysteine, folate, vitamin B-12, and 10-y incidence of age-related macular degeneration. Am J Clin Nutr (2013) 2.75
Common variants near CAV1 and CAV2 are associated with primary open-angle glaucoma. Nat Genet (2010) 2.75
A Phase I dose-escalation study of sibrotuzumab in patients with advanced or metastatic fibroblast activation protein-positive cancer. Clin Cancer Res (2003) 2.73
Cerebral white matter lesions, retinopathy, and incident clinical stroke. JAMA (2002) 2.72
Long-term use of aspirin and age-related macular degeneration. JAMA (2012) 2.72
Components of the metabolic syndrome and risk of cardiovascular disease and diabetes in Beaver Dam. Diabetes Care (2002) 2.70
The Los Angeles Latino Eye Study: design, methods, and baseline data. Ophthalmology (2004) 2.68
Clinical update: new treatments for age-related macular degeneration. Lancet (2007) 2.65
Hypertensive retinopathy. N Engl J Med (2004) 2.65
ACE-I and ARBs in early diabetic nephropathy. J Renin Angiotensin Aldosterone Syst (2002) 2.64
Macular and nerve fiber layer thickness in amblyopia: the Sydney Childhood Eye Study. Ophthalmology (2009) 2.64
Quantitative retinal venular caliber and risk of cardiovascular disease in older persons: the cardiovascular health study. Arch Intern Med (2006) 2.60
Prevalence of mitochondrial 1555A-->G mutation in adults of European descent. N Engl J Med (2009) 2.57
A randomized clinical trial of a single dose of intravitreal triamcinolone acetonide for neovascular age-related macular degeneration: one-year results. Arch Ophthalmol (2003) 2.56
Effect of candesartan on prevention (DIRECT-Prevent 1) and progression (DIRECT-Protect 1) of retinopathy in type 1 diabetes: randomised, placebo-controlled trials. Lancet (2008) 2.49
The natural history and prognosis of neovascular age-related macular degeneration: a systematic review of the literature and meta-analysis. Ophthalmology (2007) 2.46
AUSDRISK: an Australian Type 2 Diabetes Risk Assessment Tool based on demographic, lifestyle and simple anthropometric measures. Med J Aust (2010) 2.44
Genome-wide association study identifies susceptibility loci for open angle glaucoma at TMCO1 and CDKN2B-AS1. Nat Genet (2011) 2.42
Ancestral LOXL1 variants are associated with pseudoexfoliation in Caucasian Australians but with markedly lower penetrance than in Nordic people. Hum Mol Genet (2007) 2.42
Improving vision to prevent falls in frail older people: a randomized trial. J Am Geriatr Soc (2007) 2.42
Older drivers in Australia: trends in driving status and cognitive and visual impairment. J Am Geriatr Soc (2009) 2.37
Genome-wide meta-analyses of multiancestry cohorts identify multiple new susceptibility loci for refractive error and myopia. Nat Genet (2013) 2.36
The prevalence and risk factors of retinal microvascular abnormalities in older persons: The Cardiovascular Health Study. Ophthalmology (2003) 2.36
Meta-analysis of genome scans of age-related macular degeneration. Hum Mol Genet (2005) 2.34
The eye in hypertension. Lancet (2007) 2.32
Clinical risk factors for age-related macular degeneration: a systematic review and meta-analysis. BMC Ophthalmol (2010) 2.32
Generic medications in ophthalmology. Br J Ophthalmol (2012) 2.29
Natural history of branch retinal vein occlusion: an evidence-based systematic review. Ophthalmology (2010) 2.27
Computer-assisted measurement of retinal vessel diameters in the Beaver Dam Eye Study: methodology, correlation between eyes, and effect of refractive errors. Ophthalmology (2004) 2.26
The effect of cataract surgery on neuropsychological test performance: a randomized controlled trial. J Int Neuropsychol Soc (2006) 2.22
ASGE Bariatric Endoscopy Task Force systematic review and meta-analysis assessing the ASGE PIVI thresholds for adopting endoscopic bariatric therapies. Gastrointest Endosc (2015) 2.19
Generational differences in the prevalence of hearing impairment in older adults. Am J Epidemiol (2009) 2.18
Retinal arteriolar diameter and risk for hypertension. Ann Intern Med (2004) 2.18
Fluid and nutrient intake and risk of chronic kidney disease. Nephrology (Carlton) (2011) 2.18
Meta-analysis of Dense Genecentric Association Studies Reveals Common and Uncommon Variants Associated with Height. Am J Hum Genet (2010) 2.15
Effect of candesartan on microalbuminuria and albumin excretion rate in diabetes: three randomized trials. Ann Intern Med (2009) 2.14
Prevalence of diabetic retinopathy in adult Latinos: the Los Angeles Latino eye study. Ophthalmology (2004) 2.12
Prevalence and risk factors for diabetic retinopathy: the Singapore Malay Eye Study. Ophthalmology (2008) 2.11
Prospective cohort study of retinal vessel diameters and risk of hypertension. BMJ (2004) 2.10
Low birthweight is associated with narrower arterioles in adults. Hypertension (2008) 2.08
Association of A1C and fasting plasma glucose levels with diabetic retinopathy prevalence in the U.S. population: Implications for diabetes diagnostic thresholds. Diabetes Care (2009) 2.08
Imaging of the macula indicates early completion of structural deficit in autosomal-dominant optic atrophy. Ophthalmology (2013) 2.08
Age-related macular degeneration and risk for stroke. Ann Intern Med (2006) 2.07
Metamorphopsia assessment before and after vitrectomy for macular hole. Invest Ophthalmol Vis Sci (2009) 2.07
Intraocular pressure asymmetry and undiagnosed open-angle glaucoma in an older population. Am J Ophthalmol (2004) 2.07
Retinal microvascular abnormalities and 10-year cardiovascular mortality: a population-based case-control study. Ophthalmology (2003) 2.04